Traws Pharma finalizes interim CEO Iain Dukes' employment; Jack Stover named Chairman

Traws Pharma, Inc.

Employment agreement with Iain Dukes effective April 1, 2025: base salary $610K, target bonus 50% of base.
Term of one year, auto-renew; severance only after first anniversary unless change in control.
Dr. Dukes stepped down as Chairman on April 15, 2025; director Jack Stover appointed Chairman.
Dr. Dukes remains a board member after transitioning chairman role.
Agreement replaces April 2024 offer letter; details in Exhibit 10.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.